Taysha Gene Therapies (TSHA)'s 30-day implied volatility (IV30) was 41.1% at the close on November 17, 2026, down from 71.8% the day before, against a 52-week range of 39.8% to 122.3%. Its 20-day historical volatility was 68.6%.
Data as of November 17, 2026.